Literature DB >> 22159818

Spinal inflammation by magnetic resonance imaging in patients with ankylosing spondylitis: association with disease activity and outcome parameters.

Sefika Konca1, Dilek Keskin, Deniz Cılız, Hatice Bodur, Bülent Sakman.   

Abstract

Magnetic resonance imaging (MRI) has major contribution in early diagnosis of ankylosing spondylitis (AS). As it is difficult to determine disease activity owing to the lack of close relation between laboratory tests, clinical findings and imaging, MRI has been used as an objective outcome measure. The aim of this study is to investigate the relation between spinal MRI findings with disease activity and other outcome measures. Fifty patients fulfilling modified New York criteria for AS were enrolled to the study. All the patients were evaluated with Bath AS Disease Activity Index (BASDAI), AS Disease Activity Score (ASDAS), Bath AS Functional Index (BASFI), Bath AS Metrology Index (BASMI), Bath AS Radiology Index (BASRI) and As Quality of Life. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were measured as laboratory parameters, and ASspiMR scores were determined by spinal MRI. The median total ASspiMR-a score was 5.2. Spinal inflammation was evaluated in spinal segments, and thoracic segments had the highest mean ASspiMR-a level (3.1 ± 5.94). Cervical and lumbar ASspiMR were correlated with only BASRI, and total ASspiMR score was correlated with BASRI, BASMI and CRP. Thoracic ASspiMR score was correlated with patient's and doctor's global assessments, BASFI, BASMI, BASRI, ASDAS A, ASDAS B, ASDAS C, ASDAS D, ESR and CRP (P < 0.05). According to our results, the thoracic spine was the most related region with disease activity parameters and clinical outcome measures, so we suggest thoracic spine MRI evaluation in order to determine the disease activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22159818     DOI: 10.1007/s00296-011-2248-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  24 in total

1.  Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems.

Authors:  J Braun; X Baraliakos; W Golder; K-G Hermann; J Listing; J Brandt; M Rudwaleit; S Zuehlsdorf; M Bollow; J Sieper; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2004-04-05       Impact factor: 19.103

Review 2.  The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria?

Authors:  Martin Rudwaleit; Muhammad A Khan; Joachim Sieper
Journal:  Arthritis Rheum       Date:  2005-04

Review 3.  Imaging in spondylitis.

Authors:  Désirée van der Heijde; Robert Landewé
Journal:  Curr Opin Rheumatol       Date:  2005-07       Impact factor: 5.006

Review 4.  Imaging study scores for ankylosing spondylitis.

Authors:  Daniel Wendling; Eric Toussirot; Gérald Streit; Clément Prati
Journal:  Joint Bone Spine       Date:  2006-09-20       Impact factor: 4.929

Review 5.  [Imaging in ankylosing spondylitis].

Authors:  J Braun; M Rudwaleit; K G Hermann; R Rau
Journal:  Z Rheumatol       Date:  2007-03       Impact factor: 1.372

6.  Identification of acute phase reactants and cytokines useful for monitoring infliximab therapy in ankylosing spondylitis.

Authors:  Consuelo Romero-Sánchez; William H Robinson; Beren H Tomooka; John Londoño; Rafael Valle-Oñate; Feng Huang; Xiaohu Deng; Liyun Zhang; Chunhua Yang; David Tak Yan Yu
Journal:  Clin Rheumatol       Date:  2008-06-20       Impact factor: 2.980

7.  A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity.

Authors:  Yesim Akkoc; Altinay Goksel Karatepe; Servet Akar; Yesim Kirazli; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2004-01-17       Impact factor: 2.631

8.  The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment.

Authors:  K MacKay; C Mack; S Brophy; A Calin
Journal:  Arthritis Rheum       Date:  1998-12

9.  Adaptation of the Bath Ankylosing Spondylitis Functional Index to the Turkish population, its reliability and validity: functional assessment in AS.

Authors:  Burcu Yanik; Yeşim Kurtaiş Gürsel; Sehim Kutlay; Saime Ay; Atilla Halil Elhan
Journal:  Clin Rheumatol       Date:  2004-09-08       Impact factor: 2.980

10.  The Bath metrology index as assessed by a trained and an untrained rater in patients with spondylarthropathy: a study of intra- and inter-rater agreements.

Authors:  O R Madsen; L B Hansen; A Rytter; C Suetta; C Egsmose
Journal:  Clin Rheumatol       Date:  2008-08-26       Impact factor: 2.980

View more
  4 in total

1.  Value of diffusion-weighted magnetic resonance imaging in early diagnosis of ankylosing spondylitis.

Authors:  Fei Ai; Tao Ai; Xiaoming Li; Daoyu Hu; Wei Zhang; John N Morelli
Journal:  Rheumatol Int       Date:  2012-01-03       Impact factor: 2.631

Review 2.  Ankylosing spondylitis: A state of the art factual backbone.

Authors:  Mohammad Ghasemi-Rad; Hosam Attaya; Emal Lesha; Andrea Vegh; Tooraj Maleki-Miandoab; Emad Nosair; Nariman Sepehrvand; Ali Davarian; Hamid Rajebi; Abdolghader Pakniat; Seyed Amirhossein Fazeli; Afshin Mohammadi
Journal:  World J Radiol       Date:  2015-09-28

3.  Correlation of serum MMP3 and other biomarkers with clinical outcomes in patients with ankylosing spondylitis: a pilot study.

Authors:  Dongyi He; Qi Zhu; Quan Zhou; Qing Qi; Hongmei Sun; Liza M Zachariah; Grace Wang; John D Reveille; Yongtao Guan; Xiaodong Zhou
Journal:  Clin Rheumatol       Date:  2017-04-22       Impact factor: 2.980

Review 4.  Construct validity of clinical spinal mobility tests in ankylosing spondylitis: a systematic review and meta-analysis.

Authors:  Marcelo P Castro; Simon M Stebbings; Stephan Milosavljevic; Melanie D Bussey
Journal:  Clin Rheumatol       Date:  2015-09-04       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.